Xencor has completed a $45 million round of investment. MedImmune Ventures, Novo Nordisk, and HealthCare Ventures all participated with existing investor Zen Investments. This brings total venture funds raised by Xencor to $130 million. Most of the most will go to its drug development programs. Xencor was a 2005 Fierce 15 winner.
- here's the report from SoCalTech